[1]
Jong Kil, W. et al. 2013. Hypofractionated passively scattered proton radiotherapy for low- and intermediate-risk prostate cancer is not associated with post-treatment testosterone suppression. Acta Oncologica. 52, 3 (Apr. 2013), 492–497. DOI:https://doi.org/10.3109/0284186X.2013.767983.